Bari Kowal joined Regeneron in 2015 and became Head of Global Clinical Operations in 2017. She currently serves as Senior Vice President, Development Operations and Portfolio Management and is responsible for clinical trial strategy and execution, along with overseeing its development of shared services functions. She was previously at Pfizer where she held the positions of Vice President, Business Operations and Analytics, and, prior to that, Vice President, Strategic Alliance and Development Operations Lead. Ms. Kowal also served as Vice President, Clinical Operations on the clinical research organization side of the industry and at a number of biotech organizations in a variety of clinical research roles early in her career. She holds a BS in Biology from Binghamton University and an MS in Neuroscience from New York University.